Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
or
Mycophenolate Mofetil/Sirolimus Maintenance Therapy after Calcineurin Inhibitor Withdrawal in Renal Transplant Recipients: 2-Year Outcomes of the Spare-the-Nephron (STN) Trial.
À¶Ý®ÊÓƵ
Mycophenolate Mofetil/Sirolimus Maintenance Therapy after Calcineurin Inhibitor Withdrawal in Renal Transplant Recipients: 2-Year Outcomes of the Spare-the-Nephron (STN) Trial. 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation Weir, M., Mulgaonkar, S., Pearson, T., Patel, A., Patel, D., Shidban, H., Scandling, J. WILEY-BLACKWELL. 2009: 200–201View details for